PINNA, Gerard Aime
 Distribuzione geografica
Continente #
NA - Nord America 30.898
AS - Asia 6.342
SA - Sud America 4.139
EU - Europa 4.108
AF - Africa 257
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 1
Totale 45.794
Nazione #
US - Stati Uniti d'America 30.693
BR - Brasile 3.675
SG - Singapore 2.478
CN - Cina 2.226
UA - Ucraina 1.717
DE - Germania 648
HK - Hong Kong 530
SE - Svezia 414
IT - Italia 368
FI - Finlandia 292
VN - Vietnam 231
TR - Turchia 211
GB - Regno Unito 205
AR - Argentina 179
RU - Federazione Russa 112
BD - Bangladesh 93
FR - Francia 86
IQ - Iraq 86
IN - India 80
EC - Ecuador 75
ZA - Sudafrica 72
MX - Messico 71
CA - Canada 67
MA - Marocco 62
VE - Venezuela 53
UZ - Uzbekistan 50
CO - Colombia 44
JP - Giappone 43
PK - Pakistan 43
BE - Belgio 42
PL - Polonia 36
ID - Indonesia 34
TN - Tunisia 32
KE - Kenya 31
PY - Paraguay 31
CL - Cile 27
PE - Perù 26
AU - Australia 25
CZ - Repubblica Ceca 25
JO - Giordania 24
KR - Corea 23
AZ - Azerbaigian 21
IR - Iran 21
NL - Olanda 18
NP - Nepal 18
UY - Uruguay 18
ES - Italia 17
EU - Europa 17
AE - Emirati Arabi Uniti 16
EG - Egitto 16
IE - Irlanda 16
AL - Albania 15
DO - Repubblica Dominicana 14
KZ - Kazakistan 14
OM - Oman 14
RO - Romania 13
AT - Austria 12
DZ - Algeria 12
LB - Libano 11
SN - Senegal 10
BG - Bulgaria 9
BO - Bolivia 9
IL - Israele 9
JM - Giamaica 9
PS - Palestinian Territory 9
RS - Serbia 9
BH - Bahrain 8
CR - Costa Rica 8
GE - Georgia 8
LT - Lituania 8
MD - Moldavia 8
PA - Panama 8
HN - Honduras 7
KG - Kirghizistan 7
AM - Armenia 6
VG - Isole Vergini Britanniche 6
BY - Bielorussia 5
SK - Slovacchia (Repubblica Slovacca) 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CI - Costa d'Avorio 4
KH - Cambogia 4
ML - Mali 4
PH - Filippine 4
XK - ???statistics.table.value.countryCode.XK??? 4
DK - Danimarca 3
GT - Guatemala 3
HU - Ungheria 3
MN - Mongolia 3
NG - Nigeria 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AO - Angola 2
BN - Brunei Darussalam 2
CH - Svizzera 2
ET - Etiopia 2
GY - Guiana 2
IS - Islanda 2
LV - Lettonia 2
Totale 45.757
Città #
Dallas 23.747
Chandler 1.419
Singapore 1.262
Jacksonville 1.023
Princeton 546
Hong Kong 522
Dearborn 503
Nanjing 489
Beijing 418
Ashburn 252
Wilmington 249
São Paulo 239
Ann Arbor 211
New York 180
Shanghai 162
Nanchang 154
Izmir 117
Sassari 117
Rio de Janeiro 116
Los Angeles 115
Shenyang 113
Boardman 111
Woodbridge 111
Hebei 105
Changsha 97
Belo Horizonte 94
Ho Chi Minh City 92
Tianjin 77
Santa Clara 72
Jiaxing 69
Andover 67
Brasília 67
Kunming 62
Buffalo 60
Curitiba 53
San Francisco 51
Hanoi 49
Munich 49
Tashkent 48
Porto Alegre 45
Jinan 44
Brussels 41
San Mateo 41
Ningbo 40
Tokyo 40
Buenos Aires 39
Baghdad 38
Guarulhos 35
Johannesburg 34
Ribeirão Preto 33
Toronto 33
Campinas 31
Sorocaba 31
Fortaleza 30
Guayaquil 30
Hangzhou 30
Helsinki 30
Norwalk 29
Zhengzhou 29
Guangzhou 28
Salvador 28
Houston 27
Istanbul 27
Leawood 27
Nairobi 27
Santo André 27
Warsaw 27
Orem 26
Caxias do Sul 25
Goiânia 25
Mountain View 25
Osasco 25
Recife 25
Quito 24
São José do Rio Preto 24
Amman 23
Contagem 23
Dhaka 22
Monmouth Junction 22
Montreal 22
Rome 22
Seoul 22
São José dos Campos 22
Taizhou 22
Augusta 21
Baku 21
Campo Grande 21
Chicago 21
Denver 21
London 21
Bogotá 20
Tunis 20
Lanzhou 19
Lima 19
Stockholm 19
Casablanca 18
Columbus 18
Manaus 18
Uberlândia 18
Boston 17
Totale 34.920
Nome #
1,10-phenanthrolines derived from natural occurring ketones as ligands for asymmetric catalysis: enantioselective palladium catalyzed allylic substitution 10.346
1,10-Phenanthrolines derived from naturally occurring ketones as ligands for asymmetric catalysis: enantioselective palladium catalyzed allylic substitution 10.311
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 260
A new selective pre-column ninhydrin-based derivatization for a RP-HPLC determination of plasma asymmetric dimethyl-L-arginine (ADMA) by fluorescence detection 239
A hydrophilic interaction ultraperformance liquid chromatography (HILIC-UPLC) method for genomic DNA methylation assessment by UV detection 221
A diethylpyrocarbonate-based derivatization method for the LC-MS/MS measurement of plasma arginine and its chemically related metabolites and analogs 220
A new general regression-based approach for method comparison studies 208
Addition reactions of acetylenic esters to 6,7-dihydrobenzo[b]furan-4-(5H)-one, 6,7-dihydroindol-4(5H)-one, 5,6-dihydrobenzo[b]furan-7(6H)-one and 5,6-dihydroindol-7(6H)-one ketoximes. Formation of reduced furo[g]- and pyrrole[g]indoles 180
An easy route to optically active 1-substituted-1-pyridyl-methylamines by diastereoselective reduction of enantiopure N-tert-butanesulfinyl ketimines 166
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 161
Addiction reaction of acetylenic esters upon 6-substituted-a-tetralon ketoximes and conversion of the adducts into 4,5-dihydro-1H-benz[g]indoles 160
Addiction reaction of acetylenic esters upon 6-substituted-a-tetralon ketoximes and conversion of the adducts into 4,5-dihydro-1H-benz[g]indoles 159
Chiral 8-Amino Substituted 2-Phenyl-5,6,7,8-tetrahydro-6,6-dimethylmathanoquinolines as Chiral Ligands for Enantioselective Catalysis: Palladium Catalysed Allylic Substitution and Addition of Diethylzinc to Benzaldehyde 157
Chiral 8-amino substituted 2-phenyl-5,6,7,8-tetrahydro-6,6-dimethylmethanoquinolines as chiral ligands for enantioselective catalysis: Palladium catalysed allylic substitution and addition of diethylzinc to benzaldehyde 157
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 153
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 153
Composti farmaceutici 147
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 144
Approcci terapeutici contro il cancro. Tradizione e innovazione. 144
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 139
Application of an unusual ninhydrin-based reaction for the indirect chiral resolution of D,L-penicillamine 139
3,6-Diazabicyclo[3.1.1]heptane derivatives with analgesic activity 138
Ex vivo impact of functionalized carbon nanotubes on human immune cells 136
4-Carbamoyl-5-aryl-6-methyl-4,5-dihydro-3(2H)pyridazinones. New analgesic agents 135
Oxadiazoles having antiproliferative activity 131
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 131
Microemulsions 128
Bisbenzo[g]indoli: sintesi e attività citostatica 128
CAPITOLO 41. Antielmintici 127
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 126
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 126
A facile and general synthesis of 2,5,6-trisubstituted-6,7-dihydro-1,3,4-oxadiazepines 125
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 125
3,9-diazabicyclo[3.3.1]nonane derivatives with analgesic activity 124
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 124
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 123
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 123
D-Penicillamine Interferes With S-Homocysteinylation and S-Cysteinylation of LDL Apolipoprotein B 123
A survey of Recent Patents on CB2 Agonists in the Management of Pain 123
Alternative approaches to (Z)-1,2-bis(2-bromopyridin-3-yl)ethenes, key intermediates in the synthesis of the 1,10-phenanthroline core 122
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 122
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 121
Pyridazine N-oxides. I. Synthesis and in vitro antimicrobial evaluation of 3-methyl-4-aryl-6-R-pyridazine N-oxides 120
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 119
Pharmaceutical compounds 118
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 117
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 116
Improved rapid assay of plasma uric acid by short-end injection capillary zone electrophoresis 115
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 114
Addition reaction of acetilenic esters upon 1-(2-thienyl) and 1-(3-thienyl)-ethanone oximes and upon 6,7-dihydrobenzo[b]thiophen-7(4H)-one oximes. Formation of 2-thienyl-pyrroles and 4,5-dihydro-1H-th 114
A FACILE SYNTHESIS OF 3-ARYL-4-PYRAZOLEACETIC ACIDS AND OF THEIR 4,5-DIHYDRO DERIVATIVES 113
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 112
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 112
Pyridazine N-oxides. II. Synthesis and in vitro antimicrobial evaluation of 3-chloro-4-carbamoyl-5-aryl-6-methyl-pyridazine N-oxides 111
Synthesis and dopamine D2-like receptor binding affinity of substituted 5-phenyl-pyrrole-3-carboxamides 110
Chimica farmaceutica 110
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 109
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 109
Sintesi e attività microbiologica in vitro di 3-cloro-4-carbamoil-5-aril-6-metil-piridazine N-ossidi 108
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 108
Pharmaceutical Compounds 107
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 107
The organic chemistry of drug design and drug action 107
Pharmaceutical Compounds 107
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 106
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 106
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 106
NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile 105
Enantioselective Addition of Diethylzinc to Benzaldehydes in the Presence of Sulfur-Containing Pyridine Ligands 105
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 105
Development of an LC-Tandem Mass Spectrometry Method for the Quantitative Analysis of Hercynine in Human Whole Blood 105
Novel pyrazole derivatives as neutral CB1 antagonists with significant activity towards food intake 104
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 104
Synthesis and pharmacological evaluation of 4a-methyl-4,4a,5,6-tetrahydrothieno[2,3-h]cinnolin-3(2H)-ones 103
Chromophore-modified bis-benzo[g]indolecarboxamides: synthesis and citotoxicity of bis-benzo[g]indazole-3-carboxamides and related compounds 103
Tricyclic condensed pyrazole derivatives as CB1inhibitors 102
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 102
Nuovi leganti di tipo P-N: sintesi ed applicazione in catalisi asimmetrica della (2R,4R)-2,4-metano 3,3-dimetil-5-(difenilfosfanil)-1,2,3,4-tetraidroacridina 101
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 4,4A-DIHYDRO-5H-[1]BENZOPYRANO[4,3-C]PYRIDAZIN-3(2H)-ONES BIOISOSTERS OF ANTIHYPERTENSIVE AND ANTITHROMBOTIC BENZO[H]CINNOLINONES 101
Synthesis and in vitro anticancer activity evaluation of biscarbamic esters of 2,3-bis(hydroxymethyl)-1-methyl-7- and 7,8-substituted- benzo[g]indoles 101
CONFORMATIONALLY RESTRICTED CONGENERS OF HYPOTENSIVE AND PLATELET-AGGREGATION INHIBITORS - 6-ARYL-5-METHYL-4,5-DIHYDRO-3(2H)-PYRIDAZINONES DERIVED FROM 5H-INDENO[1,2-C]PYRIDAZINE 101
Tricyclic pyrazole derivatives and microemulsions thereof as CB1 and/or CB2 inhibitors. 101
Diazacyclic compounds having affinity for opioid receptors 100
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 99
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 99
Tricyclic pyridazines: a versatile substrate for pharmacologically active compounds 99
RIGID CONGENERS OF ARYLPYRIDAZINONES .4. SYNTHESIS AND ACTIVITY OF DERIVATIVES OF THE NEW HETEROCYCLIC SYSTEM 9H-INDENO[2,1-C]PYRIDAZINE 99
Pharmaceutical compounds 98
Derivati del 3,6-Diazabiciclo[3.1.1]eptano ad attività analgesica 98
Pharmaceutical Compounds 98
Tricyclic pyrazoles. An Efficient approach to cannabinoid analogues with a tricyclic framework incorporating the pyrrole and pyrazole moieties 98
Investigation on the synthesis of α-methylarylacetic acid by direct α-methylation of arylacetonitriles 98
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 97
Oxadiazoles having anti proliferative activity 97
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 97
Novel diazabicycloalkane delta opioid agonists 97
ANTIHYPERTENSIVE AND ANTITHROMBOTIC ACTIVITIES OF 6-(SUBSTITUTED PHENYL)-5-HYDROXYMETHYL-4,5-DIHYDRO-3(2H)PYRIDAZINONES 97
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 96
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 96
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 96
Totale 32.708
Categoria #
all - tutte 127.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.281 0 0 0 0 0 89 276 23 318 315 213 47
2021/20221.330 200 19 22 9 8 9 81 111 120 71 124 556
2022/20232.715 307 132 73 457 275 469 10 325 467 16 114 70
2023/2024709 130 43 28 19 79 124 5 58 3 23 75 122
2024/20257.194 48 51 409 109 295 212 450 1.289 2.805 1.018 284 224
2025/202627.160 335 7.884 16.267 1.812 707 155 0 0 0 0 0 0
Totale 45.970